1. Home
  2. ESPR vs ALCO Comparison

ESPR vs ALCO Comparison

Compare ESPR & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • ALCO
  • Stock Information
  • Founded
  • ESPR 2008
  • ALCO 1960
  • Country
  • ESPR United States
  • ALCO United States
  • Employees
  • ESPR N/A
  • ALCO N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • ESPR Health Care
  • ALCO
  • Exchange
  • ESPR Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • ESPR 220.0M
  • ALCO 242.9M
  • IPO Year
  • ESPR 2013
  • ALCO N/A
  • Fundamental
  • Price
  • ESPR $1.40
  • ALCO $32.06
  • Analyst Decision
  • ESPR Buy
  • ALCO
  • Analyst Count
  • ESPR 6
  • ALCO 0
  • Target Price
  • ESPR $6.50
  • ALCO N/A
  • AVG Volume (30 Days)
  • ESPR 5.1M
  • ALCO 19.3K
  • Earning Date
  • ESPR 08-05-2025
  • ALCO 08-12-2025
  • Dividend Yield
  • ESPR N/A
  • ALCO 0.62%
  • EPS Growth
  • ESPR N/A
  • ALCO N/A
  • EPS
  • ESPR N/A
  • ALCO N/A
  • Revenue
  • ESPR $259,574,000.00
  • ALCO $49,419,000.00
  • Revenue This Year
  • ESPR $6.10
  • ALCO $15.05
  • Revenue Next Year
  • ESPR N/A
  • ALCO N/A
  • P/E Ratio
  • ESPR N/A
  • ALCO N/A
  • Revenue Growth
  • ESPR 12.99
  • ALCO 23.36
  • 52 Week Low
  • ESPR $0.69
  • ALCO $24.23
  • 52 Week High
  • ESPR $3.94
  • ALCO $34.31
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 58.85
  • ALCO 46.55
  • Support Level
  • ESPR $1.13
  • ALCO $32.15
  • Resistance Level
  • ESPR $1.74
  • ALCO $32.66
  • Average True Range (ATR)
  • ESPR 0.17
  • ALCO 0.46
  • MACD
  • ESPR 0.01
  • ALCO -0.09
  • Stochastic Oscillator
  • ESPR 30.61
  • ALCO 3.30

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: